Fluidigm (FLDM) Reaches $4.81 After 8.00% Up Move; Shorts at Merus NV (MRUS) Lowered By 7.57%

October 12, 2017 - By Adrian Mccoy

The stock of Fluidigm Corporation (NASDAQ:FLDM) is a huge mover today! About 59,247 shares traded. Fluidigm Corporation (NASDAQ:FLDM) has declined 36.51% since October 12, 2016 and is downtrending. It has underperformed by 53.21% the S&P500.The move comes after 6 months positive chart setup for the $185.21 million company. It was reported on Oct, 12 by Barchart.com. We have $5.19 PT which if reached, will make NASDAQ:FLDM worth $14.82M more.

Merus NV (NASDAQ:MRUS) had a decrease of 7.57% in short interest. MRUS’s SI was 128,200 shares in October as released by FINRA. Its down 7.57% from 138,700 shares previously. With 9,100 avg volume, 14 days are for Merus NV (NASDAQ:MRUS)’s short sellers to cover MRUS’s short positions. The SI to Merus NV’s float is 4.03%. About 3,272 shares traded. Merus NV (NASDAQ:MRUS) has 0.00% since October 12, 2016 and is . It has underperformed by 16.70% the S&P500.

Since May 9, 2017, it had 1 buying transaction, and 1 insider sale for $5,073 activity. $49,511 worth of stock was sold by JONES EVAN/ FA on Tuesday, June 6. COLELLA SAMUEL D bought $44,438 worth of Fluidigm Corporation (NASDAQ:FLDM) on Tuesday, May 9.

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The company has market cap of $185.21 million. The Firm operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. It currently has negative earnings. The Company’s products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits , and assays and reagents.

Among 5 analysts covering Fluidigm (NASDAQ:FLDM), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Fluidigm has $28 highest and $4.4 lowest target. $12.24’s average target is 154.47% above currents $4.81 stock price. Fluidigm had 20 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Fluidigm Corporation (NASDAQ:FLDM) has “Buy” rating given on Thursday, January 7 by Deutsche Bank. The rating was upgraded by Zacks on Friday, August 21 to “Sell”. The stock has “Neutral” rating by Mizuho on Friday, August 7. Piper Jaffray maintained Fluidigm Corporation (NASDAQ:FLDM) on Monday, September 4 with “Hold” rating. The stock of Fluidigm Corporation (NASDAQ:FLDM) has “Hold” rating given on Thursday, August 27 by Maxim Group. The company was maintained on Friday, August 4 by Cowen & Co. Mizuho upgraded the stock to “Buy” rating in Friday, February 5 report. The company was downgraded on Friday, August 7 by Piper Jaffray. The rating was maintained by Mizuho with “Hold” on Sunday, August 9. Mizuho maintained it with “Neutral” rating and $8 target in Friday, October 30 report.

Analysts await Fluidigm Corporation (NASDAQ:FLDM) to report earnings on November, 2. They expect $-0.34 earnings per share, up 32.00% or $0.16 from last year’s $-0.5 per share. After $-0.39 actual earnings per share reported by Fluidigm Corporation for the previous quarter, Wall Street now forecasts -12.82% EPS growth.

Investors sentiment decreased to 1.21 in 2017 Q2. Its down 0.10, from 1.31 in 2017Q1. It worsened, as 7 investors sold Fluidigm Corporation shares while 22 reduced holdings. 11 funds opened positions while 24 raised stakes. 23.63 million shares or 3.80% less from 24.56 million shares in 2017Q1 were reported. Northern reported 406,560 shares. State Board Of Administration Of Florida Retirement System has 27,408 shares for 0% of their portfolio. Paloma Partners Mgmt invested 0% in Fluidigm Corporation (NASDAQ:FLDM). Art Ltd Com accumulated 18,848 shares or 0% of the stock. Bridgeway Capital Mngmt Inc reported 0.01% of its portfolio in Fluidigm Corporation (NASDAQ:FLDM). Morgan Stanley has invested 0% in Fluidigm Corporation (NASDAQ:FLDM). Invesco Limited stated it has 13,314 shares or 0% of all its holdings. Adage Cap Group Limited Liability holds 1.95 million shares or 0.02% of its portfolio. New York State Common Retirement Fund holds 0% of its portfolio in Fluidigm Corporation (NASDAQ:FLDM) for 26,300 shares. Glenmede Trust Company Na accumulated 235 shares or 0% of the stock. Citigroup Inc, a New York-based fund reported 74 shares. State Street Corporation holds 499,524 shares. Renaissance Ltd Liability Corporation reported 0% of its portfolio in Fluidigm Corporation (NASDAQ:FLDM). Alliancebernstein L P reported 45,700 shares or 0% of all its holdings. Orbimed Advsrs Ltd Company has 0.07% invested in Fluidigm Corporation (NASDAQ:FLDM) for 1.75 million shares.

Merus NV is a biotechnology company based in the Netherlands. The company has market cap of $406.66 million. The Firm develops differentiating therapeutics for cancer patients. It currently has negative earnings. The product programs in the Merus pipeline are based on the Biclonics format.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.